Panacea Innovation
Major shareholder at Atara Biotherapeutics · 5 reported transactions in 1 company · latest trade Jan 12, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +53.9%, S&P 500 +9.8% over the same days.
Their trades
Sold | Jan 12, 2026 | Jan 12, 2026 close $5.88 → Oct 27, 2026 close $8.40. S&P 500 +10.7% over the same days. | ||
Bought | Aug 15, 2025 | Aug 15, 2025 close $12.29 → Oct 27, 2026 close $8.40. S&P 500 +19.6% over the same days. | ||
Bought | Jul 17, 2025 | Jul 17, 2025 close $9.71 → Oct 27, 2026 close $8.40. S&P 500 +22.6% over the same days. |
$489K
Jan 12, 2026 close $5.88 → Oct 27, 2026 close $8.40. S&P 500 +10.7% over the same days.
BoughtAtara Biotherapeutics
$670.4K
Aug 15, 2025 close $12.29 → Oct 27, 2026 close $8.40. S&P 500 +19.6% over the same days.
BoughtAtara Biotherapeutics
$186.4K
Jul 17, 2025 close $9.71 → Oct 27, 2026 close $8.40. S&P 500 +22.6% over the same days.